Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

20. August 2008 12:52 ET | Quelle: DelSite, Inc.

DelSite Files IND for Nasal Powder H5N1 (Bird Flu) Influenza Vaccine

* First Nasal Powder Vaccine Against Bird Flu * Moving to Clinical Development Stage * Platform Suitable for Pandemic Preparedness and Epidemic Control * Significant...
18. August 2008 12:37 ET | Quelle: DelSite, Inc.

DelSite Biotechnologies Nasal Powder Vaccine Platform Highlighted At Cambridge Healthtech Institute

* Third Annual Immunotherapeutics and Vaccine Summit * New Approach to Vaccine Delivery * Significant advantages over Current Vaccine Technologies * Lead Product Candidate-GelVac(tm) Nasal...
14. August 2008 10:16 ET | Quelle: DelSite, Inc.

DelSite Reports Second Quarter 2008 Results

Company Fully Focused On Commercial Development of Vaccine, Drug Delivery and Adjuvant Technologies Conference Call Scheduled for 4:30 pm Eastern Today IRVING, Texas,...
04. August 2008 12:31 ET | Quelle: DelSite, Inc.

DelSite Subsidiary Sabila Industrial in Costa Rica Completes ISO 9001:2000 Inspection

* Sabila Industrial ISO-Certified for More Than Five Years * No Significant Incidences of Nonconformance Found * Continued Dedication to Quality IRVING, Texas, Aug....
31. Juli 2008 10:55 ET | Quelle: DelSite, Inc.

DelSite Sells Wound Care Division to Medline Industries

IRVING, Texas, July 31, 2008 (PRIME NEWSWIRE) -- DelSite, Inc. (OTCBB:DSII), a drug and vaccine delivery technology company, today announced it has entered into an agreement to sell its Carrington(r)...
31. Juli 2008 07:59 ET | Quelle: DelSite, Inc.

DelSite's New Stock Symbol is DSII.OB

IRVING, Texas, July 31, 2008 (PRIME NEWSWIRE) -- DelSite, Inc. (OTCBB:CARN) (OTCBB:DSII), a drug and vaccine delivery technology company, said its common shares will trade on the OTCBB under the new...
15. Juli 2008 10:11 ET | Quelle: DelSite, Inc.

DelSite Advances Nasal Delivery of Therapeutic Peptide

-- GelVac(tm) Nasal Powder Platform Delivers Peptide Arginine-Vasopressin (AVP) Into Systemic Circulation -- Peptide Widely Used to Control Urine Output in Patients With Diabetes...
08. Juli 2008 08:59 ET | Quelle: DelSite, Inc.

Carrington Laboratories, Inc. Changes Its Name to DelSite, Inc.

IRVING, Texas, July 8, 2008 (PRIME NEWSWIRE) -- DelSite, Inc. (OTC:CARN) officially became the name of Carrington Laboratories, Inc. on June 30, 2008. The name change was approved by the company's...
26. Juni 2008 12:44 ET | Quelle: DelSite, Inc.

DelSite Biotechnologies Announces Master Service Agreement With Accelovance, Inc. for Clinical Services

* First Nasal Powder H5N1 Influenza Vaccine Candidate * Distinct Advantages for Pandemic Preparedness * Phase I Dose-Escalating Study IRVING, Texas, June 26,...
26. Juni 2008 08:59 ET | Quelle: DelSite, Inc.

DelSite Announces Development of Unique Synthetic Typhoid Vi Polysaccharide Vaccine Candidate

* Safer and More Economical Approach Against a Major Infectious Disease That Causes 500,000 to 600,000 Deaths Worldwide Per Year * Chemical Composition Similar to Marketed Typhoid...

Nächste Seite